320 related articles for article (PubMed ID: 30084572)
1. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
3. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
4. Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy.
Corrao G; Monzio Compagnoni M; Cantarutti A; Rea F; Merlino L; Catapano AL; Mancia G
Diabetes Res Clin Pract; 2020 Jun; 164():108197. PubMed ID: 32389742
[TBL] [Abstract][Full Text] [Related]
5. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
Rochlani Y; Kattoor AJ; Pothineni NV; Palagiri RDR; Romeo F; Mehta JL
Am J Cardiol; 2017 Oct; 120(7):1122-1128. PubMed ID: 28797470
[TBL] [Abstract][Full Text] [Related]
6. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors.
Go AS; Ambrosy AP; Kheder K; Fan D; Sung SH; Inveiss AI; Romo-LeTourneau V; Thomas SM; Koren A; Lo JC;
Am J Cardiol; 2020 Feb; 125(4):534-541. PubMed ID: 31848029
[TBL] [Abstract][Full Text] [Related]
7. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
[TBL] [Abstract][Full Text] [Related]
8. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
[TBL] [Abstract][Full Text] [Related]
9. Statins and the potential for higher diabetes mellitus risk.
Yandrapalli S; Malik A; Guber K; Rochlani Y; Pemmasani G; Jasti M; Aronow WS
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):825-830. PubMed ID: 31474169
[No Abstract] [Full Text] [Related]
10. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.
Sasso FC; Lascar N; Ascione A; Carbonara O; De Nicola L; Minutolo R; Salvatore T; Rizzo MR; Cirillo P; Paolisso G; Marfella R;
Cardiovasc Diabetol; 2016 Oct; 15(1):147. PubMed ID: 27733159
[TBL] [Abstract][Full Text] [Related]
11. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
[TBL] [Abstract][Full Text] [Related]
12. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
13. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
14. Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease.
Pletcher MJ; Pignone M; Jarmul JA; Moran AE; Vittinghoff E; Newman T
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28188251
[TBL] [Abstract][Full Text] [Related]
15. Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.
Kamran H; Kupferstein E; Sharma N; Karam JG; Myers AK; Youssef I; Sowers JR; Gustafson DR; Salifu MO; McFarlane SI
Cardiorenal Med; 2018; 8(2):105-112. PubMed ID: 29617000
[TBL] [Abstract][Full Text] [Related]
16. Time to improve statin prescription guidelines in low-risk patients?
Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
[TBL] [Abstract][Full Text] [Related]
17. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Yebyo HG; Aschmann HE; Puhan MA
Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
[TBL] [Abstract][Full Text] [Related]
18. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
19. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality.
Lavie G; Hoshen M; Leibowitz M; Benis A; Akriv A; Balicer R; Reges O
Am J Med; 2021 May; 134(5):643-652. PubMed ID: 33217370
[TBL] [Abstract][Full Text] [Related]
20. Population health impact of statin treatment in Canada.
Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
